Harmon Seth
SEC CIK 1993300 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | CFO | 7,850 | — | — | 3 | 2026-03-03 | 2026-03-03 |
Most active insiders at VRDN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | $20.00M | — |
| 2 | Fairmount Healthcare Fund II GP LLC | Dir, 10% | $10.00M | — |
| 3 | Tousignant Jennifer | CLO | — | $419.0K |
| 4 | Harmon Seth | CFO | — | — |
| 5 | Tripuraneni Radhika | Chief Medical Off | — | — |
| 6 | Mahoney Stephen F. | Pres, CEO, Dir | — | — |
| 7 | Beetham Thomas W. | COO | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-03-09 | 2026-03-03 | VRDN | Viridian Therapeutics, Inc.\DE | Harmon Seth | CFO | F - Tax | $30.19 | -2,031 | 7,850 | -21% | -$61.3K |
| D | 2026-03-04 | 2026-03-03 | VRDN | Viridian Therapeutics, Inc.\DE | Harmon Seth | CFO | M - OptEx | — | +6,267 | 9,881 | +173% | — |
| D | 2026-03-04 | 2026-03-03 | VRDN | Viridian Therapeutics, Inc.\DE | Harmon Seth | CFO | F - Tax | $29.32 | -2,091 | 7,790 | -21% | -$61.3K |
Purchase Sale Sale after option exercise All abbreviations